COMMITMENTS AND CONTINGENCIES: (Details Narrative) - USD ($)															12 Months Ended
	Jul. 26, 2023	Jun. 23, 2023	May 02, 2023	Apr. 24, 2023	Jan. 17, 2023	Jun. 15, 2022	May 02, 2022	Apr. 30, 2022	Mar. 31, 2022	Mar. 23, 2022	Jan. 28, 2022	Aug. 01, 2018	Oct. 10, 2016	Feb. 10, 2015	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021	May 01, 2022	Dec. 29, 2021	Sep. 30, 2021	Feb. 28, 2018	Apr. 27, 2017	Oct. 31, 2016	Sep. 25, 2014
Loss Contingencies [Line Items]
Compensation increased							$ 25,000
Cash compensation paid															$ 249,744	$ 346,846
Exercise bonus																	75.00%
Warrants held by trust owned																	$ 3,000,000
Warrants and Rights Outstanding															18,438,339
Debt instrument paid amount											$ 2,665,500
Debt Instrument, Interest Rate During Period									25.00%		25.00%					25.00%
Principal, interest				$ 83,275	$ 533,100						$ 666,375
Paid invoice amount			$ 83,275
Aggregate payment			$ 2,615,500												2,615,500
Purchase order	$ 50,000							$ 50,000
Capitalized labor and interest costs															4,182,260
Capitalized labor and interest costs paid															3,962,207
Capitalized labor and interest costs yet to pay															220,053
Capitalized labor and interest costs															6,103,693
Sale of domain, description										the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490.
Accrued interest																			$ 2,255,802
Total assets															7,593,633	$ 6,360,337				$ 297
Total liabilities															3,361,954	7,254,916			10,234,501	10,154,334
Accounts payable and accrued liabilities															677,137	1,360,644			10,009,802	9,939,148
Accounts payable																			212,263	214,235
Accrued Liabilities, Current																			$ 12,436	$ 950
Gain on legal dissolution of subsidiary															$ 10,234,501
Loans as a liability																	9,868,495
Bank account hacked amount		$ 75,000
Weighted average remaining lease term															1 year 6 months 29 days
Discounted rate															10.00%
P A 1 [Member]
Loss Contingencies [Line Items]
Debt Instrument, Debt Default, Amount																								$ 8,137,117
Realized from the asset sale						$ 104,725
Pennvest Loan [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity															$ 7,754,000
Debt Instrument, Annual Principal Payment															5,886,000
Long-Term Debt, Maturity, Year Two															846,000
Long-Term Debt, Maturity, Year Three															873,000
Long-Term Debt, Maturity, Year Four															$ 149,000
Interest Expense, Debt																123,444	$ 246,887
Pennvest Loan [Member] | Years One Through Five [Member]
Loss Contingencies [Line Items]
Debt Instrument, Interest Rate During Period															2.547%
Pennvest Loan [Member] | Years Six Through Maturity [Member]
Loss Contingencies [Line Items]
Debt Instrument, Interest Rate During Period															3.184%
Minimum [Member]
Loss Contingencies [Line Items]
Warrants exercisable per share															$ 0.60
Exercise bonus															50.00%
Maximum [Member]
Loss Contingencies [Line Items]
Warrants exercisable per share															$ 2.40
Exercise bonus															90.00%
Smith [Member]
Loss Contingencies [Line Items]
Cash compensation paid															$ 5,000
Cash compensation paid															200,000	$ 130,000
William O Neill [Member]
Loss Contingencies [Line Items]
Payment for cash															$ 12,500
President [Member]
Loss Contingencies [Line Items]
Monthly Officers Cash Compensation													$ 18,000
President [Member] | Extension Bonus [Member] | Fy 2016 Extension Agreement [Member]
Loss Contingencies [Line Items]
Deferred Compensation, Maximum Convertible Amount																						$ 300,000	$ 125,000
Deferred Compensation, Stock Conversion, Price Per Share (in dollars per share)																						$ 0.75	$ 0.75
President [Member] | Warrants Issused Subscription Receivable [Member]
Loss Contingencies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)															300,000	300,000
Warrants exercisable per share															$ 0.60
President [Member] | Warrants Issued In Connection With Sale Of Units In Exchange For Salary [Member]
Loss Contingencies [Line Items]
Warrants exercisable per share															$ 0.75
Chief Executive Officer [Member]
Loss Contingencies [Line Items]
Monthly Officers Cash Compensation														$ 31,000	$ 25,000
Warrants exercisable per share																		$ 1.00
Cash compensation paid															5,000
Cash compensation paid															150,000	$ 25,000
Deferred Compensation, Maximum Convertible Amount															$ 10,000
Exercise price adjustment provision Percentage															75.00%
Exercise bonus																		75.00%
Number of shares issued																		1,000,000
Cancellation of warrants																		700,000
Chief Executive Officer [Member] | Secured Promissory Note Consideration For Warrants Expiring On December 312025 [Member]
Loss Contingencies [Line Items]
Cash compensation paid															$ 5,000
Financing Receivable, after Allowance for Credit Loss, Total															361,321
Repayments of Long-term Debt, Total															$ 300,000	$ 250,000
Chief Executive Officer [Member] | Warrants Issused Subscription Receivable [Member]
Loss Contingencies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)															5,565,000
Chief Executive Officer [Member] | Warrants Expiring On December 312025 [Member]
Loss Contingencies [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)												3,000,000
Bassani [Member]
Loss Contingencies [Line Items]
Salaries and wages																					$ 31,000
Additional paid amount																					$ 2,000
Interest bearing secured promissory note												$ 300,000